Leaders from two of the top five cancer centers, as ranked by U.S. News & World Report, shared with Becker's the best leadership advice they have received.
The Latest
Imfinzi, a drug manufactured by AstraZeneca, has been approved by the FDA for treatment of early-stage, non-small cell lung cancer in combination with chemotherapy.
Wakefield, R.I.-based South County Health experienced a staffing shake-up this summer after three hematology oncology providers resigned due to "chronic underfunding."
Seven health organizations are using Cancer Moonshot funds to reimagine and advance cancer surgery, Politico reported Aug. 14.
Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open.
The Biden administration will dole out up to $150 million in research funding awards as part of its Cancer Moonshot initiative.
Tuscaloosa, Ala.-based DCH Regional Medical Center is reopening the hospital's oncology unit, WVUA 23 reported Aug. 12.
Global cancer deaths among men are projected to increase more than 93% from 5.4 million in 2022 to 10.5 million in 2050, according to a study published Aug. 12 in the American Cancer Society journal Cancer.
When Eileen Hacker, PhD, APRN, was overcome with emotion upon being inducted into the International Nurse Researcher Hall of Fame. When reached by Becker's, she called it an honor and a privilege.
Cannabis users are 3.5 to five times more likely to develop head and neck cancers, a recent Los Angeles-based Keck Medicine of USC study found.